Eswatini vs South Korea: New cases tested for RR-/MDR-TB
Eswatini
100.0%
in 2024
South Korea
100.0%
in 2024
Eswatini rank
1st
South Korea rank
1st
New cases tested for RR-/MDR-TB over time
- Eswatini
- South Korea
How they compare
Eswatini currently reports 100.0% against 100.0% in South Korea, a difference of 0.0%.
The two have swapped places 2 times across 11 shared years of data; in 2013 it was South Korea ahead.
Eswatini ranks 1st and South Korea ranks 1st of 192 countries.
Across the 2 decades both report, Eswatini averaged higher in 1 and South Korea in 1.
Head to head by decade
| Decade | Eswatini | South Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 78.5% | 85.3% | 6.8% | South Korea |
| 2020s | 100.0% | 94.2% | 5.8% | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Eswatini or South Korea?
- Eswatini, at 100.0% against 100.0% in South Korea as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Eswatini and South Korea?
- 0.0%, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and South Korea?
- 11 years are reported by both, from 2013 to 2024.
- How do Eswatini and South Korea rank globally for new cases tested for rr-/mdr-tb?
- Eswatini ranks 1st and South Korea ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.